BioDot and Kinematic Automation Announce a Co-Marketing Agreement to offer the Medical Diagnostic Industry Complete Solutions for Automated Manufacturing
Strategic agreement formed to support cooperation and co-innovation in point-of-care test manufacturing.
Irvine and Twain Harte, California
BioDot, one of the world’s foremost providers of low volume dispensing equipment and Kinematic Automation, the high production automation systems experts, announced a new strategic co-marketing agreement. The agreement will combine BioDot’s expertise in dispensing equipment for point of care devices with Kinematic’s market leading high production automation expertise to deliver solutions for today’s global device manufacturing world.
This collaboration provides customers with a full complement of combined products, expertise and technology from the industry leaders in manufacturing for diagnostics. Today we are seeing an increase in demand for healthcare and thus diagnostic tests. That increase, coupled with test device innovations and miniaturization, means that more specialization is needed from diagnostic manufacturing equipment suppliers. Combining the skills and products from BioDot and Kinematic is a natural way to accomplish that. BioDot and Kinematic are working together to establish a global offering to the market.
Tom Tisone, CEO, BioDot commented “As we enter a new era of miniaturization and multiplexing in diagnostic devices combined with the need of high throughput manufacturing, companies must co-innovate to solve tough problems for their customers. This is why we are working with Kinematic, a market leader in high throughput manufacturing. This new offer represents our belief that the future requires the experts to create a new operating model, where collaboration becomes a necessity of doing business.”
“This collaboration is long overdue and will provide customers with a real and comprehensive source for complete solutions to their automation needs. By combining Kinematic’s expertise in manufacturing to improve product quality and increase manufacturing throughput with BioDot’s portfolio of reagent dispensing systems, we can develop and define exciting new opportunities for device manufacturers. ” said Ted Meigs, Co-Founder, Kinematic Automation.
Founded in 1994, BioDot manufactures precision quantitative fluid dispensing systems. Today with nearly 5000 units in the field BioDot is the single largest supplier of equipment in the diagnostic test market. Specializing in low volume dispensing, our wide range of platforms serve our customers from R&D through high volume manufacturing in the industrial, diagnostic, life science and medical product markets. Our portfolio of proprietary dispensing technologies provide precision, non-contact dispensing from picoliter to microliter volumes. Today BioDot holds over 26 global patents in the area of low volume dispensing and novel applications that rely on its proprietary dispensing technology. BioDot is worldwide company with international offices in China and the United Kingdom. Our long-lasting relationships with customers are built on precision products and quality service around the world.
Kinematic was founded in 1980 and for 35 years has focused much of its design and development activities on innovative manufacturing solutions for the test strip industry. With numerous patents and proprietary technologies uniquely designed for lateral flow and blood glucose test strips, Kinematic is a global leader in high-speed automated test strip manufacturing. Kinematic’s well-known Matrix™ brand offers robust, high-throughput technologies for dispensing reagents, laminating membranes, cutting test strips and assembling test strip cassettes.